Literature DB >> 27685916

Thymidylate synthase polymorphism in Mexican patients with colon cancer treated with 5-fluorouracil.

Clara Patricia Rios-Ibarra1, Claudia Janeth Rodriguez-Silva, Yamil Alonso Lopez-Chuken, Rocio Ortiz-Lopez, Elisa Fernandez-Castillo, Claudia Beatriz Del Toro Runzer, Vicente Paul Armenta-Perez, Juan Pablo Flores-Gutierrez, Arturo Quintanilla-Guzman, Mauricio Salinas-Santander, Juan Francisco Gonzalez-Guerrero, Francisco Bosques-Padilla, Arturo Santos, Herminia Guadalupe Martinez-Rodriguez.   

Abstract

PURPOSE: We analyzed the genotype and allele frequency of variable number tandem repeats (VNTR)-thymidylate synthase (TS) and its relationship with the disease evolution in colon cancer patients.
METHODS: We selected 24 paraffin-embedded colon cancer tissue samples from Mexican patients who received a 5-fluorouracil (5-FU)-based chemotherapy regimen. Tumor tissue was digested with proteinase K and genomic DNA was isolated by the standard method with phenol-chloroform extraction. Polymerase chain reaction (PCR) was performed for TS genotyping of VNTR and the results were evaluated directly in a stained agarose gel.
RESULTS: The allele frequency of 2 repeats (2R) was greater (0.66) than 3R (0.34) in metastatic colon cancer (x2=10.24; p=0.001)) however, no difference in allelic distribution between 2R (0.54) and 3R (0.46) in non metastatic patients was observed (x2=0.640; p=0.424).
CONCLUSION: Our results suggest that Mexican patients with colon cancer present differences in the allelic distribution, the 2R allele being the most frequent.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27685916

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  1 in total

1.  Transcriptome profiling analysis reveals biomarkers in colon cancer samples of various differentiation.

Authors:  Tonghu Yu; Huaping Zhang; Hong Qi
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.